Vimarsana
Biggest News Aggregation in the World

Patrickg Enright News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrickg Enright. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrickg Enright Today - Breaking & Trending Today

Vera Therapeutics : Submission of Matters to a Vote of Security Holders - Form 8-K - Vimarsana News

Vera Therapeutics : Submission of Matters to a Vote of Security Holders - Form 8-K

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ... | May 17, 2023

Molecular Templates : 10-K/A Filing FY 2022 - Vimarsana News

Molecular Templates : 10-K/A Filing FY 2022

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ... | April 28, 2023

Vera Therapeutics, Inc. (NASDAQ:VERA) Expected to Post Q1 2022 Earnings of ($0.67) Per Share - Vimarsana News

Vera Therapeutics, Inc. (NASDAQ:VERA) Expected to Post Q1 2022 Earnings of ($0.67) Per Share

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Rating) – Wedbush issued their Q1 2022 EPS estimates for Vera Therapeutics in a report issued on Monday, April 18th. Wedbush analyst L. Chico anticipates that the company will post earnings per share of ($0.67) for the quarter. Wedbush has a “Outperform” rating and a $32.00 price objective on […]

Wedbush Initiates Coverage on Vera Therapeutics (NASDAQ:VERA) - Vimarsana News

Wedbush Initiates Coverage on Vera Therapeutics (NASDAQ:VERA)

Equities research analysts at Wedbush began coverage on shares of Vera Therapeutics (NASDAQ:VERA – Get Rating) in a report issued on Monday, The Fly reports. The brokerage set an “outperform” rating on the stock. VERA has been the topic of several other reports. Zacks Investment Research lowered Vera Therapeutics from a “hold” rating to a […]

Vera Therapeutics, Inc. (NASDAQ:VERA) Director Patrick G. Enright Purchases 333,333 Shares - Vimarsana News

Vera Therapeutics, Inc. (NASDAQ:VERA) Director Patrick G. Enright Purchases 333,333 Shares

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Rating) Director Patrick G. Enright acquired 333,333 shares of the business’s stock in a transaction dated Thursday, February 10th. The shares were purchased at an average price of $15.00 per share, with a total value of $4,999,995.00. The acquisition was disclosed in a legal filing with the SEC, which […]